The Montreal Fertility Centre

What The Montreal Fertility Centre does

The Montreal Fertility Centre is a private fertility clinic founded in 2002 in Montreal, Quebec, providing comprehensive assisted reproductive technology (ART) services to individuals and couples facing infertility, including heterosexual couples, single women, and same-sex couples. Clinical leadership consists of two reproductive endocrinology specialists — Dr. Mahutte (Medical Director, joined 2007) and Dr. Ouhilal — supported by Chief Embryologist Hanane Lachgar (15+ years' experience) and an in-house psychologist, Gabriela Legorreta.

The clinic's embryology lab offers IVF, ICSI, IUI, blastocyst culture, vitrification, advanced computerized semen analysis, and a proprietary non-invasive embryo screening technology with Harvard research backing. Reported clinical pregnancy rates include 40% for fresh IVF cycles, 37% for frozen embryo transfers, 47% for patients under 35, and 60% for fresh egg donation cycles. Between January 2020 and December 2022, the clinic performed 651 fresh IVF cycles and 913 frozen-thaw transfers.

Revenue is generated fee-for-service across three payer segments: Quebec RAMQ-insured residents (public coverage, including the expanded IVF coverage introduced under Bill 73 in November 2021), domestic private-pay patients, and an international self-pay program with published tiered pricing ranging from approximately $3,500 for a frozen embryo transfer to $18,000 for a donor IVF cycle. The 11–50 employee operation runs two Montreal offices with bilingual service delivery and positions itself as a clinically differentiated, patient-experience-focused alternative to larger Quebec ART networks.

Name

The Montreal Fertility Centre

Legal name

The Montreal Fertility Center

Website

https://www.montrealfertility.com/

Company type

Private

Founded year

2002

Operating status

Operating

Headcount range

11–50 employees

Short description

The Montreal Fertility Centre is a private Montreal-based fertility clinic founded in 2002, offering IVF, ICSI, IUI, egg freezing, and donor services to Quebec RAMQ-insured residents, domestic private-pay patients, and international patients, supported by a Harvard-backed non-invasive embryo screening program.

Ownership category

akta.pro rank

Product category

Reproductive Health and Fertility Services

NAICS

Ambulatory Health Care Services (621)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

Fertility, Reproductive Endocrinology & IVF Centers (HLAFAJAD)

akta.pro secondary industry

Reproductive Endocrinology & Infertility (IVF/Fertility) (HLAKAJAC)

Keywords

• Fertility treatments
• In vitro fertilization
• Egg freezing services
• Infertility diagnostics
• Assisted reproductive technology

Headquarters

HQ city

Montréal

HQ country

Canada

HQ region

North America

Offices2 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Supply Chain

Revenue model

1. Fertility Treatment Services: Fee-for-service model for fertility treatments including IVF, IUI, egg freezing, donor services, and diagnostic procedures. RAMQ (Quebec public health insurance) covers most treatments for eligible patients. Non-RAMQ patients pay out-of-pocket according to published fee schedule. Medication costs are classified as medicament d'exception and covered by private insurance or RAMQ with monthly co-pay.
2. Consultation Services: Initial and follow-up consultations. Free for patients with valid Quebec RAMQ card. $500 for non-RAMQ patients.
3. Fertility Medications: Medications are covered by private insurance (typically 80% of cost) or RAMQ (minus monthly deductible of approximately $80) for eligible patients. A Medicament d'Exception form must be completed by the treating physician for coverage.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Core offering

The Montreal Fertility Centre is a private fertility clinic that diagnoses and treats infertility through assisted reproductive technologies. It offers IVF, ICSI, IUI, donor insemination, egg donation, social egg freezing, embryo cryopreservation, and infertility investigations as billable clinical services for individual patients. Treatments are provided on a fee-for-service basis, with most services covered by Quebec's RAMQ provincial health plan for eligible residents and paid out-of-pocket by non-resident and international patients.

Product overview

The Montreal Fertility Centre is a single-location private fertility clinic founded in 2002, offering a comprehensive suite of assisted reproductive technologies as a unified clinical service rather than a modular software platform. The core portfolio is organized around in vitro fertilization (IVF) as the primary treatment, with ICSI, intrauterine insemination (IUI), donor insemination (DI), egg donation, and egg freezing (social fertility preservation) as the main service lines. These are supported by complementary add-on modules including blastocyst culture, embryo cryopreservation via vitrification, frozen-thaw embryo transfer (FET), laser assisted hatching, non-invasive embryo culture media analysis for chromosomal screening (PGT-A), ovarian stimulation with anti-estrogens or gonadotropins, and infertility investigations (semen analysis, hormonal testing, ultrasound, sonohysterogram). The clinic also provides specialized international patient services with a structured 3-step remote treatment protocol, and participates in the Quebec RAMQ Program under Bill 73 covering eligible treatments. Patient education is supported through medication teaching videos for all prescribed fertility drugs. The clinic reports overall clinical pregnancy rates of 40% for fresh IVF cycles (Jan 2020–Dec 2022, N=651) and 37% for frozen-thaw embryo transfers (N=913).

Differentiator

Problem solved

Functional benefit

Products and services

• In Vitro Fertilization (IVF) Core assisted reproduction treatment involving ovarian stimulation with gonadotropins, egg retrieval, laboratory fertilization, embryo culture, and embryo transfer for individuals and couples experiencing infertility. Reported clinical pregnancy rate of 40% for fresh cycles (651 transfers, Jan 2020-Dec 2022) and 47% for women under 35.
• Intrauterine Insemination (IUI) Insemination procedure for couples with mild male factor or unexplained infertility in which washed sperm is injected into the uterus just prior to ovulation to increase pregnancy chances. Covered by RAMQ for eligible Quebec patients under Bill 73 up to 6 cycles for women aged 18-40.
• Donor Insemination (DI) Treatment using donor sperm from internationally respected, Health Canada-compliant sperm banks for patients with azoospermia, failed IVF/ICSI/TESA/PESA, or single/same-sex couples. Donor sperm purchase is covered by RAMQ for covered assisted reproduction cycles.
• Egg Donation Treatment for patients with insufficient ovarian reserve, poor egg quality, or advanced maternal age using either a known/identified donor or frozen donor eggs purchased from commercial egg banks. Includes ovarian stimulation, egg retrieval, and synchronized embryo transfer, with reported live birth rates of 50-55% for fresh donor egg cycles and approximately 40% for frozen donor eggs.
• Egg Freezing (Social Egg Freezing) Vitrification-based cryopreservation of eggs for age-related fertility preservation, involving ovarian stimulation, transvaginal egg retrieval, and freezing of mature eggs. Reported freeze-thaw survival rates of 80-90% and fertilization rates of 70-80% for frozen-thawed eggs. Covered by RAMQ for cancer patients who are RAMQ eligible.
• Infertility Investigations Comprehensive diagnostic testing including computerized semen analysis (available 7:30-9:30 AM Monday-Friday), hormonal testing (FSH, estrogen, AMH), antral follicle count ultrasound, transvaginal ultrasound, sonohysterogram (SHG), hysterosalpingography (HSG), and prenatal blood work. Designed to be completed within 3-4 weeks with immediate treatment start.
• Ovarian Stimulation and Ovulation Induction Medication-based stimulation using two regimens: first-line oral anti-estrogens (clomiphene citrate or letrozole) with 8-10% per-cycle pregnancy rates, and second-line injectable gonadotropins (FSH) with 10-15% per-cycle pregnancy rates, with ultrasound monitoring to time ovulation for timed intercourse or IUI.
• Non-Invasive Embryo Culture Media Screening Non-invasive chromosomal screening that analyzes the culture media in which blastocysts have grown to assess whether embryos are likely to have the correct number of chromosomes, without damaging the embryo through biopsy. Research from Harvard (Huang et al., 2019) reports detection of over 90% of abnormal embryos and recognition of over 80% of normal embryos, with a 50% live birth rate reported after transfer of a chromosomally normal blastocyst.

Quantifiable outcome

• 40% clinical pregnancy rate for fresh IVF cycles (651 transfers, January 2020 - December 2022)
• +5 more outcomes

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

One partnership is on record.

• Internationally Respected Sperm Banks (Health Canada Compliant)coreTechnology or IntegrationThe clinic works with internationally respected sperm banks that meet Health Canada criteria, which are among the strictest in the world. Donors undergo intensive screening including complete medical and social history, family history, genetic disorder screening, sexually transmitted disease testing, and HIV screening. Frozen specimens are quarantined for six months and only released if donors remain disease-free.

Scale indicators7 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• CReATe Fertility Centre: Toronto-based fertility clinic offering IVF, ICSI, egg donation, and preimplantation genetic testing. Comparable private, physician-led Canadian fertility practice with disclosed success rates and a focus on advanced reproductive technologies.
• Procrea (Clinique de Procréation Assistée): Montreal-based fertility clinic offering IVF, IUI, donor gametes and fertility preservation. Closest geographic direct competitor, also serving Quebec RAMQ-eligible patients under the same Bill 73 framework.
• Olive Fertility Centre: Vancouver-based private fertility clinic offering IVF, ICSI, egg freezing and genetic screening. Comparable multi-physician Canadian fertility practice with disclosed outcomes and a self-referral model.
• Pacific Centre for Reproductive Medicine (PCRM): British Columbia-based fertility clinic group offering IVF, IUI, egg donation and fertility preservation. Comparable Canadian fertility practice with multiple locations and disclosed pregnancy rate reporting.
• First Steps Fertility: Toronto-based private fertility clinic offering IVF, ICSI, egg freezing and donor services. Comparable physician-led Canadian ART provider serving self-referring patients with transparent fee schedules.
• Trio Fertility: Toronto-based fertility clinic offering IVF, ICSI, egg freezing and LGBTQ+-family-building services. Comparable Canadian private fertility practice with disclosed success rates and a multi-physician team.
• Markham Fertility Centre: Markham (Greater Toronto Area) fertility clinic offering IVF, IUI, donor gametes and reproductive surgery. Comparable physician-led Canadian fertility practice with self-referral intake and published outcomes.
• Conceptia Fertility Clinic: Moncton, New Brunswick-based fertility clinic offering IVF, IUI, egg donation and fertility preservation. Comparable regional Canadian fertility practice serving Atlantic Canada with public-pay coverage structures analogous to Quebec's.
• NewLife Fertility Centre: Multi-location Ontario fertility clinic network offering IVF, ICSI, egg freezing and genetic testing. Comparable Canadian ART provider with a multi-site operating model that contrasts with the Montreal Fertility Centre's single-city footprint.

Regional players

• McGill University Health Centre Reproductive Centre: Hospital-based reproductive endocrinology and infertility program operating within the McGill University Health Centre in Montreal. Competes for the same Quebec patient pool under RAMQ coverage but as part of a public hospital system rather than a private clinic.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks5 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/watch?v=TT5hmTJEWw4&feature=emb_logo
• Facebookfacebook.com/LeCentredeFertilitedeMontreal
• LinkedInlinkedin.com/company/montreal-fertility-centre

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about The Montreal Fertility Centre